Extensive stage SCLC (Es-SCLC) | |
Extensive stage SCLC (Es-SCLC) - maintenance (M) | |
immune chekpoint inhibitors | |
anti-PD-(L)1 | |
nivolumab based treatment | |
nivolumab alone | CheckMate 451 ... |
Immune checkpoint association | |
nivolumab plus ipilimumab | CheckMate 451 ... |